Dr. Ing. h.c. F. Porsche AG (DRPRF)
OTCMKTS · Delayed Price · Currency is USD
51.19
+0.09 (0.17%)
Jul 31, 2025, 3:51 PM EDT

Theseus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
44,71455,10080,45692,249--
Upgrade
Market Cap Growth
-33.88%-31.52%-12.78%---
Upgrade
Enterprise Value
49,75659,25487,72396,333--
Upgrade
Last Close Price
51.1956.7685.4796.67--
Upgrade
PE Ratio
17.6014.8214.1217.40--
Upgrade
PS Ratio
0.981.331.802.29--
Upgrade
PB Ratio
1.632.313.365.07--
Upgrade
P/TBV Ratio
2.662.403.525.39--
Upgrade
P/FCF Ratio
15.0712.7414.5415.97--
Upgrade
P/OCF Ratio
7.918.3810.3612.13--
Upgrade
EV/Sales Ratio
1.111.431.962.40--
Upgrade
EV/EBITDA Ratio
5.977.358.6910.74--
Upgrade
EV/EBIT Ratio
11.3010.0210.7013.22--
Upgrade
EV/FCF Ratio
16.7713.7015.8516.68--
Upgrade
Debt / Equity Ratio
0.470.490.480.560.420.41
Upgrade
Debt / EBITDA Ratio
1.471.311.041.031.251.24
Upgrade
Debt / FCF Ratio
4.302.712.071.752.886.09
Upgrade
Asset Turnover
0.740.770.830.760.680.65
Upgrade
Inventory Turnover
3.924.304.485.385.605.29
Upgrade
Quick Ratio
0.740.960.990.871.060.97
Upgrade
Current Ratio
1.441.411.481.221.421.34
Upgrade
Return on Equity (ROE)
9.58%16.08%26.65%24.85%18.71%16.82%
Upgrade
Return on Assets (ROA)
4.76%6.87%9.45%8.61%7.24%6.26%
Upgrade
Return on Capital (ROIC)
7.47%10.75%15.84%14.41%11.47%10.26%
Upgrade
Return on Capital Employed (ROCE)
10.10%14.60%20.10%22.00%14.70%12.90%
Upgrade
Earnings Yield
5.68%6.75%7.08%5.75%--
Upgrade
FCF Yield
6.63%7.85%6.88%6.26%--
Upgrade
Dividend Yield
5.13%4.21%2.99%1.12%--
Upgrade
Payout Ratio
97.09%58.46%94.92%67.76%46.23%56.99%
Upgrade
Buyback Yield / Dilution
----901.10%--
Upgrade
Total Shareholder Return
5.13%4.21%2.99%-899.98%--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.